A look at innovations in Covid-19 testing, including rapid antigen (protein) tests. Could they play a part in opening up borders? What of the concerns they may miss some infectious people?
Rapid antigen tests are the same tests that The World Health Organization says it will provide 120 million of, to people in low and middle-income countries over the next six months. Another test in development is the use of salvia instead of nasal swabs.
Kathryn talks to Paul Simmonds from Border Integrity Solutions, University of Otago Clinical Microbiologist David Murdoch, and Chris Roberts from Tourism Industry Aotearoa